Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for improved wound closure employing olivamine and human umbilical vein endothelial cells

Methods for improved wound closure employing olivamine and human umbilical vein endothelial cells

US Patent 8796315 · Granted Aug 5, 2014

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Non-activated, amorphous, pH neutral, two-part bedside-ready clay delivery syste2025
Coated medicinal clay compositions, pharmaceutical compositions, and delivery of2025
Non-activated, amorphous, pH neutral, two-part bedside-ready clay delivery syste2023
Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell dea2019
Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell dea2017
Compositions for anti-inflammatory, antioxidant effects and improved respiratory2017
Nutritional supplements2016
Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell dea2015
Methods for improved wound closure employing olivamine and endothelial cells2015
Nutritional supplements2014
Compositions and methods for wound care2014